BPS Barbara Wilson Lifetime Achievement Award

12th IAU Annual Conference in 2023: London Witnesses Outstanding Gathering in the Field of Urolithiasis

Retrieved on: 
Wednesday, October 11, 2023
Conference, Quality of life, EULIS, WCE, Book, Urology, Patient, University College London Hospitals NHS Foundation Trust, BPS Barbara Wilson Lifetime Achievement Award, Guideline, Kidney, UCLH, Surgeon, European Society of Clinical Microbiology and Infectious Diseases, International Alliance of Research Universities, Minimally invasive procedure, SIU, Research, Pharmaceutical industry, Endoscopy, Kidney stone disease, IAU

From October 4th to 6th 2023, the 12th Annual Conference of IAU was grandly held in London, United Kingdom.

Key Points: 
  • From October 4th to 6th 2023, the 12th Annual Conference of IAU was grandly held in London, United Kingdom.
  • In addition to academic communication, the IAU Annual Conference presented multiple awards to recognize experts who have made outstanding contributions in the field of urolithiasis.
  • The first-ever IAU Annual Conference held in London highlighted the significant progress achieved in international collaboration in this field.
  • The 2023 IAU Annual Conference in London was a historic event in the field of urolithiasis.

World-Renowned Orthopaedics Pioneer Joseph D. Zuckerman, MD, Receives Lifetime Achievement Award

Retrieved on: 
Wednesday, September 20, 2023
Glenoid labrum, Albert Einstein College of Medicine, Surgeon, William H. Harris (orthopaedic surgeon), Education, Lifetime Achievement Emmys, Professional, NYU, American Academy, NYU Langone Health, OSET, Patient, Walter, American Academy of Orthopaedic Surgeons, BPS Barbara Wilson Lifetime Achievement Award, Faculty, Knowledge, Extremities, Health, Orthopedic surgery, MPH, Nursing, Medical device, MD

"In our 13th year of the Orthopaedic Summit, I couldn't be prouder to present the Lifetime Achievement Award to Joseph D. Zuckerman," said Kevin Plancher, MD, MPH, FAOA, FAAOS, Founder of the Orthopaedic Summit, Clinical Professor of Orthopaedics at Albert Einstein College of Medicine.

Key Points: 
  • "In our 13th year of the Orthopaedic Summit, I couldn't be prouder to present the Lifetime Achievement Award to Joseph D. Zuckerman," said Kevin Plancher, MD, MPH, FAOA, FAAOS, Founder of the Orthopaedic Summit, Clinical Professor of Orthopaedics at Albert Einstein College of Medicine.
  • "I am honored OSET chose to award me the Lifetime Achievement award," Zuckerman said.
  • I would like to thank my colleagues for their passion and sharing the same vision to advance the field of orthopaedics.
  • "Dr. Zuckerman's extensive knowledge, leadership and professionalism exemplifies why he is a recipient of the Lifetime Achievement award," said Exactech Vice President of Extremities Marketing Emery Patton.

Dr. Charmaine Lok and Dr. Allen R. Nissenson Join PatenSee's Scientific Advisory Board

Retrieved on: 
Wednesday, September 20, 2023
Ottawa Hospital Research Institute, David Geffen School of Medicine at UCLA, National Kidney Foundation, Rockwell Medical, Kidney failure, University, Emeritus, Stenosis, Teaching, Physician, Renal replacement therapy, Coronavirus Scientific Advisory Board, Research, Mentorship, Associate, University Health Network, Dialysis, ASN, Patient, NKF, Nursing, DaVita Inc., Kidney, Renal Physicians Association, Reading, BPS Barbara Wilson Lifetime Achievement Award, ISCB Senior Scientist Award, Vascular access, UCLA, Therapy, Conference, Chronic kidney disease, Kidney disease, Award, Fistula, Medical device, Pharmaceutical industry, Medicine

OR YEHUDA, Israel, Sept. 20, 2023 /PRNewswire/ -- Dr. Charmaine Lok is the new Chairperson of the PatenSee Scientific Advisory Board. The company also announced today that Dr. Allen R. Nissenson has joined the company as a strategic advisor. PatenSee is developing a contactless imaging system to provide rapid vascular access monitoring for hemodialysis patients.

Key Points: 
  • OR YEHUDA, Israel, Sept. 20, 2023 /PRNewswire/ -- Dr. Charmaine Lok is the new Chairperson of the PatenSee Scientific Advisory Board.
  • The company also announced today that Dr. Allen R. Nissenson has joined the company as a strategic advisor.
  • I am delighted to join PatenSee as the chairperson of its Scientific Advisory Board and look forward to guiding this technology's further development to rapidly make it available for improving patient outcomes," said Dr. Lok.
  • Dr. Nissenson currently serves on the Board of Directors of Elicio Therapeutics, Rockwell Medical, Innocura Nephrology and Diality Inc.

Korea University and International ESG Association (IESGA) Host a Forum on ESG and Sustainable Development

Retrieved on: 
Tuesday, September 19, 2023
United Nations Sustainable Development Group, Communication, International, Education, Psychology, APRU, Speech, Korea University, University, Research, Multimedia, Science, HCR, Springer Nature, Interdisciplinarity, Advertising, UN, BPS Barbara Wilson Lifetime Achievement Award, Consumer, Biophysical environment, Knight Bachelor, ESG, Environment, Forum, Culture of Korea, Association of British Science Writers, Tourism, Social

SEOUL, South Korea, Sept. 19, 2023 /PRNewswire/ -- The International ESG Association (IESGA), in collaboration with the APRU Sustainable Waste Management Program (APRU SWM), the Korea University ESG Research Institute, the Korean Society for Consumer and Advertising Psychology, and Springer Nature, hosted a forum with Sir Philip Campbell, titled "Routes towards a sustainable society." The forum was led by Prof. Yong Sik Ok, the HCR Professor at Korea University, the Chair and Program Director of the APRU SWM Program, as well as the President of IESGA. Prof. Jay Hyuk Rhee, the Director of the Korea University ESG Research Institute and the President of IESGA, played a key role alongside Prof. Ok. Sir Campbell, a prominent British astrophysicist, is an Honorary Fellow at Cambridge. He held the position of Editor-in-Chief of Nature for 22 years and currently serves as the Editor-in-Chief at Springer Nature. He is also a recipient of the Lifetime Achievement Award from the Association of British Science Writers (2019) and was recognized as a Knight Bachelor for his contribution to the field of science on the late Queen's birthday in 2015.

Key Points: 
  • SEOUL, South Korea, Sept. 19, 2023 /PRNewswire/ -- The International ESG Association (IESGA), in collaboration with the APRU Sustainable Waste Management Program (APRU SWM), the Korea University ESG Research Institute, the Korean Society for Consumer and Advertising Psychology, and Springer Nature, hosted a forum with Sir Philip Campbell, titled "Routes towards a sustainable society."
  • The forum was led by Prof. Yong Sik Ok, the HCR Professor at Korea University, the Chair and Program Director of the APRU SWM Program, as well as the President of IESGA.
  • He held the position of Editor-in-Chief of Nature for 22 years and currently serves as the Editor-in-Chief at Springer Nature.
  • Within the current ESG era, this Forum provided a notable platform to link ESG and the United Nations Sustainable Development Goals (UN SDGs).

Dan Drawbaugh – CEO of The Steadman Clinic and Steadman Philippon Research Institute – Named Colorado ORBIE Leadership Award Winner

Retrieved on: 
Wednesday, August 2, 2023
Roaring Fork Transportation Authority, Duquesne University, IBM, University, World Health Imaging, Telemedicine, and Informatics Alliance, Information technology, Temple University, Verizon (mobile network), United States Department of Defense, InformationWeek, CIO (magazine), AMA Foundation Leadership Award, MBA, Medicine, Bangladesh Technical Education Board, SPRI, Organization, University of Pittsburgh Medical Center, Publication, Work, Engineering, BPS Barbara Wilson Lifetime Achievement Award, Motivation, Diagnosis, CIO, UPMC, Hospital, Breast cancer, NIH, Department of Defence, Management, Daniel Drawbaugh, Oracle

Dan Drawbaugh, who has served as CEO of The Steadman Clinic and SPRI since 2015, was named the recipient of the 2023 Colorado ORBIE Leadership Award presented by ColoradoCIO at its awards ceremony in Denver on July 28.

Key Points: 
  • Dan Drawbaugh, who has served as CEO of The Steadman Clinic and SPRI since 2015, was named the recipient of the 2023 Colorado ORBIE Leadership Award presented by ColoradoCIO at its awards ceremony in Denver on July 28.
  • The Leadership Award serves as a Lifetime Achievement Award, and reflects Drawbaugh’s career from CIO to CEO.
  • “I am extremely honored to receive this ORBIE Award for Leadership in our industry,” said Drawbaugh, whose career included years of work and leadership in the information technology world.
  • During his tenure in Vail, Drawbaugh has overseen tremendous growth for both The Steadman Clinic and SPRI.

HAYA Therapeutics Adds Douglas L. Mann, M.D. as Chairperson of Clinical Advisory Board

Retrieved on: 
Tuesday, June 20, 2023
Cardiology, Biotechnology, FDA, Other Health, Diabetes, Health, Pharmaceutical, Research, Genetics, Science, Clinical Trials, Tissue, Heart, The New England Journal of Medicine, Heart failure, JAMA Cardiology, Research fellow, Cardiac fibrosis, European Society of Cardiology, RNA, Multimedia, Inflammation, Lung, NEJM, Chairperson, Heart Failure Society of America, Ada, Journal, Cell biology, Patient, Washington University School of Medicine, BPS Barbara Wilson Lifetime Achievement Award, Liver, Temple University School of Medicine, Principal, American College, Lafayette College, SA, Therapy, III, HCM, Tumor microenvironment, Physiology, Pharmaceutical industry, Medical device, Biology, Medicine

HAYA Therapeutics, SA , a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs, today announced that Douglas L. Mann, M.D.

Key Points: 
  • HAYA Therapeutics, SA , a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs, today announced that Douglas L. Mann, M.D.
  • is joining as Chairperson of the company’s Clinical Advisory Board.
  • is joining as Chairperson of the company’s Clinical Advisory Board.
  • Members of HAYA’s Clinical Advisory Board:
    “Through their platform, HAYA developed HTX-001, a targeted fibrosis-modifying therapy for heart failure.

Max Hirshkowitz, PhD, Receives National Sleep Foundation's Lifetime Achievement Award

Retrieved on: 
Monday, May 1, 2023
Consensus, BPS Barbara Wilson Lifetime Achievement Award, Polysomnography, Consumer Technology Association, NSF, Sleep, Baylor University, National Sleep Foundation, CTA, Michael E. DeBakey Veterans Affairs Medical Center in Houston, Research, Doctor of Philosophy, Sleep Research Society, Insomnia, Stanford University School of Medicine, Public health, Sleep medicine, Chairperson, Obstructive sleep apnea, NIH, Chair, Pharmaceutical industry, Nursing

WASHINGTON, May 1, 2023 /PRNewswire/ -- National Sleep Foundation (NSF) announced today that Max Hirshkowitz, PhD, has received its Lifetime Achievement Award.

Key Points: 
  • WASHINGTON, May 1, 2023 /PRNewswire/ -- National Sleep Foundation (NSF) announced today that Max Hirshkowitz, PhD, has received its Lifetime Achievement Award.
  • The Lifetime Achievement Award is the organization's highest honor, recognizing an individual who has demonstrated exemplary leadership in the field of sleep health.
  • He has authored hundreds of peer-reviewed articles and served on the editorial board of multiple journals including Sleep Health, Sleep Medicine, and Sleep Research.
  • To learn more about the National Sleep Foundation's Lifetime Achievement Award, visit the NSF website .

Renowned Vascular Surgeon Unveils Dark Side of the Medical Profession in Revealing New Memoir

Retrieved on: 
Tuesday, February 7, 2023
The New York Times, Society, Health, Cleveland, Playboy, Daily News, BPS Barbara Wilson Lifetime Achievement Award, Barnes & Noble, Society for Vascular Surgery, Patient, Disclosure, European Society of Gynaecological Oncology, Bell, Sale, New York, New York, Publishing, Cleveland Clinic, NYU, Multimedia, Environment, Medicine, MD, Hospital, Dentistry, Chicago Tribune, Los Angeles Times, Amazon

NEW YORK, Feb. 7, 2023 /PRNewswire/ -- From celebrated vascular surgeon and veteran medical maverick Dr. Frank J. Veith comes a captivating memoir and exposé of the medical establishment that unveils an often clubby industry that many believe needs serious reform.

Key Points: 
  • NEW YORK, Feb. 7, 2023 /PRNewswire/ -- From celebrated vascular surgeon and veteran medical maverick Dr. Frank J. Veith comes a captivating memoir and exposé of the medical establishment that unveils an often clubby industry that many believe needs serious reform.
  • Part captivating memoir, part disclosure of a self-serving system, The Medical Jungle recounts Dr. Veith's tireless efforts to improve medical care for patients.
  • The Medical Jungle will inspire anyone who faces adversity at any level to stand up and be radical, even when it is unpopular.
  • A starred review from Blue Ink Review calls The Medical Jungle "a fascinating chronicle of the complex inner workings of the 'medical jungle,'" while Kirkus calls the book "an engaging and evocative medical memoir."

Ionis Chief Scientific Officer C. Frank Bennett, Ph.D. to receive Rainwater Prize for Outstanding Innovation in Neurodegenerative Disease Research

Retrieved on: 
Thursday, January 26, 2023
PDUFA, Miller, Tauopathy, University, ALS, Ionis Pharmaceuticals, Neurology, Lewy body dementias, Hope, Pharmacokinetics, Nusinersen, Breakthrough Prize, Huntington's disease, Rain, IONS, Palsy, DRS, Breakthrough Prize in Life Sciences, Washington University School of Medicine, Prescription Drug User Fee Act, Alzheimer's disease, Molecular medicine, Hereditary Disease Foundation, Brain, Oligonucleotide, Patient, University of California, Research, BPS Barbara Wilson Lifetime Achievement Award, Neurodegenerative disease, Pharmaceutical industry, Ionis, Science

CARLSBAD, Calif., Jan. 26, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Chief Scientific Officer C. Frank Bennett, Ph.D., has been named a co-recipient of the Rainwater Prize for Outstanding Innovation in Neurodegenerative Disease Research.

Key Points: 
  • CARLSBAD, Calif., Jan. 26, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Chief Scientific Officer C. Frank Bennett, Ph.D., has been named a co-recipient of the Rainwater Prize for Outstanding Innovation in Neurodegenerative Disease Research.
  • The prizes will be presented during the Eurotau 2023 conference on April 27, 2023, in Lille, France.
  • Bennett, Cleveland and Miller are being recognized for their work advancing antisense technology for the treatment of neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Huntington's disease, Alzheimer's disease and tauopathies.
  • A founding member of Ionis, Dr. Bennett is responsible for continuing to advance Ionis' technology and expand its discovery platform.

Apellis Appoints Leading Retina Specialist Dr. Caroline Baumal as Chief Medical Officer

Retrieved on: 
Thursday, January 5, 2023
Tufts Medical Center, Geographic atrophy, Health, PDUFA, American Academy of Ophthalmology, McGill University, Research, Publication, BPS Barbara Wilson Lifetime Achievement Award, Patient, American Academy, Retina, Fede, Culture, University, GA, Biochemistry, Society, APLS, Pharmaceutical industry, Ophthalmology, OAKS

WALTHAM, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that leading retina specialist Caroline Baumal, M.D., has joined Apellis as chief medical officer.

Key Points: 
  • WALTHAM, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that leading retina specialist Caroline Baumal, M.D., has joined Apellis as chief medical officer.
  • “Caroline is a world-renowned retina specialist who has been at the forefront of retina research and patient care for over 25 years, and we are thrilled to welcome her to Apellis,” said Cedric Francois, M.D., Ph.D., chief executive officer and co-founder of Apellis.
  • “With a PDUFA date next month for GA, I am excited to join Apellis at this truly transformational moment.
  • “I look forward to working together with this exceptional team to advance our pipeline and bring breakthrough medicines to patients.”